Physician profile
Thomas Ross Pitts
NPI 1144341157
$1,358,055.85
in general payments reported to CMS, 2019-2025
2 companies · $651K in 2025
The $651K reported for 2025 was more than what 99% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $634 · 2020: $726 · 2021: $1,352 · 2022: $526 · 2023: $670K · 2024: $34K · 2025: $651K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.2M · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $159K · Food and Beverage: $6,894 · Entertainment: $37.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,189,187.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $158,700.00 |
| Food and Beverage | $6,893.52 |
| Entertainment | $37.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| World Class Technology Corporation | $1,358,022.50 | 2019-2025 | Pitts21, Pitts21 Pro |
| Envista Holdings Corporation | $33.35 | 2024 | Spark |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Pitts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.